Press release
Global Cancer Vaccines Market (2025-2033): Growth Outlook, Emerging Immunotherapy Innovations, and Strategic Developments Across Dendritic, DNA, and Peptide-Based Platforms
Cancer Vaccines Market
The Cancer Vaccines Market involves therapeutic and prophylactic vaccines targeting cancer-specific antigens to stimulate the immune system. Growth is driven by rising cancer prevalence, biotechnology innovations, and immunotherapy adoption. Platforms include peptide-based, DNA/RNA-based, and dendritic cell vaccines. Advances in personalized medicine, AI-assisted vaccine design, and combination therapies enhance efficacy. Clinical trials and regulatory approvals accelerate market potential. Increasing awareness and investment in oncology therapeutics support sustained growth.
📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Cancer Vaccines Market Landscape:- https://datamintelligence.com/download-sample/cancer-vaccines-market?rk
☛ Cancer Vaccines Market Recent Developments 2025:
United States:
✅ In July 2025, Moderna initiated Phase 2 trials of an mRNA-based cancer vaccine targeting multiple solid tumors.
✅ In June 2025, BioNTech expanded its personalized neoantigen vaccine platform to early-stage melanoma and lung cancer patients.
Japan:
✅ In August 2025, Takara Bio launched clinical studies for dendritic cell-based cancer vaccines.
✅ In May 2025, Kyowa Kirin developed peptide-based cancer vaccines for immunotherapy trials.
☛ Cancer Vaccines Market Competitve Landscape:
ose-immuno, Merck & Co. Inc., IO Biotech, Medigene AG, Northwest Biotherapeutics, GlaxoSmithKline, Dendreon Pharmaceuticals LLC., Dynavax Technologies Corporation, Immunophotonics, Codagenix.
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/cancer-vaccines-market
☛ Segment Covered in the Cancer Vaccines Market:
By Technology: Dendritic Cells Vaccines, Anti-idiotype Vaccines, Antigen Vaccines, Whole Tumor Vaccines, DNA Vaccines
By Type: Preventive Cancer Vaccines, Treatment Cancer Vaccines.
By Disease Type: Cervical Cancer, Prostate Cancer, Others
☛ This Report Includes:
✔ Comprehensive go-to-market strategies with actionable insights.
✔ Unbiased evaluation of overall market performance.
✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.
✔ Tailored regional and country-level reports with detailed localized analysis available on request.
✔ Identification of niche segments and high-growth regions presenting strong opportunities.
✔ Accurate regional forecasts using both top-down and bottom-up approaches.
📌 Get Corporate Access to Live Cancer Vaccines Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=cancer-vaccines-market
☛ Regional Analysis for Cancer Vaccines Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
☛ FAQ's
Q1: What is the current size of the Cancer Vaccines Market and its future potential?
A: Cancer Vaccines Market reached US$ 8.82 Billion in 2023, with a rise of US$ 9.27 Billion in 2024 and is expected to reach US$ 14.96 Billion by 2033.
Q2: How fast is the Cancer Vaccines Market expected to grow in the coming years?
A: The market is forecast to expand at a robust CAGR of 5.5% between 2025 and 2032, signaling strong global growth and investment potential.
Q3: Which regions are dominating the Cancer Vaccines Market and which are fastest-growing?
A: North America dominating the Cancer Vaccines Market.
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cancer Vaccines Market (2025-2033): Growth Outlook, Emerging Immunotherapy Innovations, and Strategic Developments Across Dendritic, DNA, and Peptide-Based Platforms here
News-ID: 4212827 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Automotive Battery Market to Hit USD 100 Billion by 2031 | Driven by EVs, Hybrid …
Global Automotive Battery Market reached USD 65.2 billion in 2022 and is expected to reach USD 100.0 billion by 2031, growing with a CAGR of 5.5% during the forecast period 2024-2031.
Automotive Battery refers to a rechargeable or non-rechargeable energy storage device used to power vehicle electrical systems and enable engine starting or propulsion. In conventional vehicles, lead-acid batteries support ignition, lighting, and onboard electronics. In electric and hybrid vehicles, advanced…
Biopharmaceutical Tubing Market Expected to Reach US$ 8.65 Billion by 2033 Drive …
The global biopharmaceutical tubing market reached US$ 4.15 Billion in 2024 and is expected to reach US$ 8.65 Billion by 2033, growing at a CAGR of 8.6% during the forecast period 2025-2033.
The biopharmaceutical tubing market covers specialized polymer and elastomer tubing used in bioprocessing, drug manufacturing, and sterile fluid transfer. These tubes are designed to meet strict regulatory standards for purity, chemical resistance, and biocompatibility. They are critical in applications…
Short Bowel Syndrome Market to Hit $7.93 Billion by 2033 | Driven by Crohn's Dis …
According to DataM Intelligence, the short bowel syndrome market was valued at US$ 1.39 Billion in 2023, grew to US$ 1.64 Billion in 2024, and is expected to reach US$ 7.93 Billion by 2033, expanding at a strong CAGR of 19.3% during 2025-2033. Growth is primarily fueled by the rising prevalence of gastrointestinal disorders such as Crohn's disease, increasing surgical resections, and innovations in GLP-2 analogs that reduce dependence on…
Krill Oil Supplements Market Expected to Reach US$ 1.48 Billion by 2031, Driven …
Global Krill Oil Supplements Market reached US$ 834.11 million in 2023 and is expected to reach US$ 1476.58 billion by 2031, growing with a CAGR of 7.4% during the forecast period 2024-2031.
According to DataM Intelligence has published a new research report on "Krill Oil Supplements Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key…
More Releases for Vaccines
Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC.
Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to…
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy…
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in…
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
